Your browser doesn't support javascript.
loading
FLEXamers: A Double Tag for Universal Generation of Versatile Peptide-MHC Multimers.
Effenberger, Manuel; Stengl, Andreas; Schober, Kilian; Gerget, Maria; Kampick, Maximilian; Müller, Thomas R; Schumacher, Dominik; Helma, Jonas; Leonhardt, Heinrich; Busch, Dirk H.
Afiliación
  • Effenberger M; Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany.
  • Stengl A; Department of Biology II, Ludwig Maximilian University of Munich, 82152 Planegg-Martinsried, Germany.
  • Schober K; Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany.
  • Gerget M; Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany.
  • Kampick M; Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany.
  • Müller TR; Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany.
  • Schumacher D; National Center for Infection Research, 85748 Munich, Germany; and.
  • Helma J; Department of Biology II, Ludwig Maximilian University of Munich, 82152 Planegg-Martinsried, Germany.
  • Leonhardt H; Department of Biology II, Ludwig Maximilian University of Munich, 82152 Planegg-Martinsried, Germany.
  • Busch DH; Department of Biology II, Ludwig Maximilian University of Munich, 82152 Planegg-Martinsried, Germany.
J Immunol ; 202(7): 2164-2171, 2019 04 01.
Article en En | MEDLINE | ID: mdl-30760621
ABSTRACT
Peptide-MHC (pMHC) multimers have become a valuable tool for immunological research, clinical immune monitoring, and immunotherapeutic applications. Biotinylated tetramers, reversible Streptamers, or dye-conjugated pMHC multimers are distinct pMHC reagents tailored for T cell identification, traceless T cell isolation, or TCR characterization, respectively. The specific applicability of each pMHC-based reagent is made possible either through conjugation of probes or reversible multimerization in separate production processes, which is laborious, time-consuming, and prone to variability between the different types of pMHC reagents. This prohibits broad implementation of different types of pMHC reagents as a standard toolbox in routine clinical immune monitoring and immunotherapy. In this article, we describe a novel method for fast and standardized generation of any pMHC multimer reagent from a single precursor ("FLEXamer"). FLEXamers unite reversible multimerization and versatile probe conjugation through a novel double tag (Strep-tag for reversibility and Tub-tag for versatile probe conjugation). We demonstrate that FLEXamers can substitute conventional pMHC reagents in all state-of-the-art applications, considerably accelerating and standardizing production without sacrificing functional performance. Although FLEXamers significantly aid the applicability of pMHC-based reagents in routine workflows, the double tag also provides a universal tool for the investigation of transient molecular interactions in general.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Linfocitos T / Separación Celular / Antígenos de Histocompatibilidad Límite: Animals / Humans Idioma: En Revista: J Immunol Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Linfocitos T / Separación Celular / Antígenos de Histocompatibilidad Límite: Animals / Humans Idioma: En Revista: J Immunol Año: 2019 Tipo del documento: Article País de afiliación: Alemania